Exploring Chemically Modified Short Activating RNAs to Increase Stability against Nucleases and Enhance Gene Activation
Short activating RNAs (saRNAs) are short duplex RNAs that activate genes in the nucleus of the cell. This induces gene activation, or RNA activation (RNAa), which upregulates gene expression. This activation is in direct contrast to short interfering RNAs (siRNAs), which downregulate gene expression through the activation of Argonaute 2 within the RNA-induced silencing complex (RISC). siRNA chemical modifications such as 2'-O-Me, 2'-F, locked nucleic acids (LNA), unlocked nucleic acids (UNA), and backbone modifications such as phosphorothioate (PS) have been well documented and studied. In this study, a library of chemically modified saRNAs was synthesized and evaluated for their ability to activate gene expression. We have identified that a thermally destabilizing abasic carbon-based linker within the central region of the sense strand, in conjunction with an affinity-enhancing nucleoside, LNA, on the antisense strand, offers optimal duplex melting temperature, nuclease stability, and enhanced gene activation.
Authors
- Sara Aguti (ORCID: https://orcid.org/0000-0001-5105-121X)
- Hannah M. Pendergraff
- Jon Voutila (ORCID: https://orcid.org/0000-0001-7193-2110)
- Jean‐Paul Desaulniers (ORCID: https://orcid.org/0000-0002-9596-4552)
- Matthew L. Hammill
- Troels Koch (ORCID: https://orcid.org/0000-0001-9224-9353)
- Nagy Habib (ORCID: https://orcid.org/0000-0003-4920-4154)
- Ifrodet Giorgees (ORCID: https://orcid.org/0000-0002-1542-598X)
- H. Hansen (ORCID: https://orcid.org/0000-0001-8879-3612)
- Yulia Lomonosova
- Virginia Wing-Nam Chiu
Institutions
- Ontario Tech University (CA)
- Opexa Therapeutics (United States) (US)
Publication Details
- Journal
- Journal of Medicinal Chemistry
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1021/acs.jmedchem.5c01648
- Primary Topic
- RNA Interference and Gene Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00